Canada Pharmaceutical Market by Distribution Channel, Type, and Therapy Area - Forecast and Analysis 2024-2028

Published: Mar 2024 Pages: 148 SKU: IRTNTR77771

Canada Pharmaceutical Market Forecast 2024-2028

The Canada pharmaceutical market size is estimated to grow by USD 8.73 billion at a CAGR of 4.6% between 2023 and 2028. 

Moreover, Canada's pharmaceutical sector thrives on robust R&D capabilities, a skilled workforce, and advanced healthcare infrastructure. Major players like Novartis AG and Pfizer Inc. invest heavily in various facets of the industry, including R&D, manufacturing, and innovation initiatives. Novartis AG, for instance, allocated USD 450 million for pharmaceutical expansions, with an annual R&D investment of USD 30 million. Pfizer Inc. partnered with Communitech, investing USD 1.4 million to foster healthcare innovation. Such substantial investments drive growth in Canada's pharmaceutical market.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Distribution Channel, Type, and Therapy Area Analysis

Life sciences companies produce vital medical items like personal protective equipment and ventilators. Healthcare workers adhere to strict security protocols, including plexiglass barriers and sanitizer use. Measures like social distancing and self-isolation are implemented. Ongoing research and development drive advancements in pharmaceuticals and biomanufacturing, crucial for combatting chronic diseases such as hypertension, osteoarthritis, and cancer.

Distribution Channel Analysis

The market share by the pharmacy segment will be significant during the forecast period. The pharmacy sector in the pharmaceutical market in Canada encompasses hospital and retail pharmacies. Hospitals maintain direct ties with drug manufacturers, ensuring a steady drug supply, negotiating prices, and upholding quality standards. They track patients' medication history for treatment monitoring and accountability, providing education on medication usage.

Get a glance at the market contribution of various segments Download PDF Sample

The pharmacy segment was valued at USD 26.79 billion in 2018. Further, retail pharmacies, known for accessibility and convenience, offer not just prescriptions but also healthcare services like consultations and vaccinations. They educate patients on medication usage, side effects, and precautions, empowering them to manage their health effectively. Both sectors contribute significantly to the pharmaceutical market, meeting diverse consumer needs and driving growth of the market during the forecast period. 

Type Analysis

The prescription?segment will account for the largest share of this segment.?As the elderly population grows, so does the demand for prescription drugs to manage chronic conditions like cardiovascular diseases, high blood pressure, and diabetes. In Canada, the availability of prescription medications has increased with advancements in medical treatments. Government policies promoting healthcare access and affordability further drive prescription drug usage. Increasing awareness among Canadians about health conditions and treatment options leads to more consultations with healthcare professionals and prescriptions. This trend supports the growth of the pharmaceutical market in Canada during the forecast period.

Buy the Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • AstraZeneca PLC: The company offers pharmaceutical products that focus on areas including Oncology, Cardiovascular, Renal and Metabolism, Respiratory and Immunology, Vaccines and Immune Therapies, Rare Diseases, and others.

Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LES LABORATOIRES SERVIER, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

In the realm of healthcare, life sciences companies play a pivotal role, producing essential medical items such as personal protective equipment and ventilators. Amidst heightened concerns, healthcare workers implement stringent security protocols, including the use of plexiglass barriers and sanitizers, alongside practices like social distancing and self-isolation. Advancements in research and development drive innovation in pharmaceuticals and biomanufacturing, yielding crucial vaccines for various ailments. The aging population faces challenges like chronic diseases such as hypertension, osteoarthritis, and cancer, necessitating the continuous launch of new OTC drugs and treatments, including those for atopic dermatitis and asthma. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Significant Trends

Increasing advancements in biotechnology is one of the primary market trends. The surge in biotechnological advancements can be attributed to the increasing emphasis on precision medicine, personalized therapies, and innovative treatment modalities, all of which are propelled by the rapid strides in biotechnological research and development. One key driver is the growing understanding of the genetic and molecular compositions of diseases. Biotechnology has enabled researchers and pharmaceutical companies in Canada to get deeper into the intricate mechanisms governing various medical conditions, paving the way for the development of targeted therapies.

Moreover, biologics are complex drugs derived from living organisms that are proving to be instrumental in treating conditions such as cancer, autoimmune disorders, and rare diseases. As a result, pharmaceutical companies are increasingly investing in research and production of biologics. Furthermore, the potential applications of such technologies are vast, ranging from correcting genetic mutations to developing entirely new therapeutic approaches. Thus, such factors will fuel market growth during the forecast period.

Major Challenges

Price controls and reimbursement policies is the major challenge that affects market growth. The Canadian government, through agencies such as the Patented Medicines Prices Review Board (PMPRB), has implemented stringent measures to control and regulate drug prices, aiming to ensure affordability and accessibility for the public. While these policies benefit consumers, they create a complex market for pharmaceutical companies operating in Canada. One major challenge is that PMPRBs focus on comparing drug prices in Canada to those in other countries with similar economic profiles. 

In addition, the Canadian Agency for Drugs and Technologies in Health (CADTH) and provincial drug plans play pivotal roles in determining which drugs receive public reimbursement. Delays in the reimbursement approval process can significantly impact a drug's market uptake and revenue generation. For instance, if a pharmaceutical company successfully brings a novel drug to market, the time it takes to secure reimbursement approval can hinder its commercial success, negatively affecting both the company's financial health and the timely availability of innovative treatments for patients. Such factors are expected to hinder the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth and forecasting by revenue and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Distribution Channel Outlook
    • Pharmacy
    • Clinic
  • Type Outlook
    • Prescription
    • Non-prescription
  • Therapy Area Outlook
    • Musculoskeletal system
    • Nervous system
    • Respiratory system
    • Others

Market Analyst Overview:

The market thrives with innovative medicines catering to various ailments like ischemic heart disease, osteoporosis, and chronic obstructive pulmonary disease. With Health Canada overseeing product launches and approvals, the sector witnesses a blend of brand-name pharmaceuticals and generic pharmaceuticals. CROs and CMOs drive research and development in patented therapies, gene and cell therapies, and nanomedicines. The market's growth is propelled by pharmaceutical sales in Canada and its contribution to the global market.

Additionally, in Canadian healthcare, the pharmaceuticals market plays a crucial role in addressing conditions like ischemic heart disease, prediabetes, and metabolic disorders. Governed by Health Canada regulations, it offers a range of Over-the-Counter (OTC) drugs for topical disorders such as atopic dermatitis. The market sees contributions from biopharmaceutical SMEs, contract research organizations (CROs), and contract manufacturing organizations (CMOs) in the research and development (R&D) of innovative drugs. With patents protecting biopharmaceuticals and brand-name products, the sector drives Canadian sales and offers solutions to various health issues.

Furthermore, in the market, various stakeholders like physicians, nurses, and volunteers collaborate to address health concerns such as ischemic heart disease (IHD) and melanoma. Governed by regulations from the Government of Canada, it caters to the geriatric population and offers treatments for conditions like atopic dermatitis. With contributions from biopharmaceutical SMEs, the market sees advancements in antihistamines, moisturizers, and antibiotics. The Canadian Dermatology Association plays a vital role in ensuring quality care and treatment options in various sub-sectors of healthcare.

Canada Pharmaceutical Market Scope

Report Coverage

Details

Page number

148

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.6%

Market Growth 2024-2028

USD 8.73 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.74

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LES LABORATOIRES SERVIER, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download the Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the between 2024 and 2028
  • Precise estimation of the size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across Canada
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Therapy Area
    • Exhibit 07: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 08: Parent market
    • Exhibit 09: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 10: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 11: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
      • Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Pharmaceutical market in Canada 2018 - 2022
      • Exhibit 16: Historic Market Size – Data Table on pharmaceutical market in Canada 2018 - 2022 ($ billion)
    • 4.2 Distribution Channel Segment Analysis 2018 - 2022
      • Exhibit 17: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 18: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.4 Therapy Area Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Therapy Area Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 21: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 22: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 23: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 24: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 25: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Distribution Channel

    • 6.1 Market segments
      • Exhibit 27: Chart on Distribution Channel - Market share 2023-2028 (%)
      • Exhibit 28: Data Table on Distribution Channel - Market share 2023-2028 (%)
    • 6.2 Comparison by Distribution Channel
      • Exhibit 29: Chart on Comparison by Distribution Channel
      • Exhibit 30: Data Table on Comparison by Distribution Channel
    • 6.3 Pharmacy - Market size and forecast 2023-2028
      • Exhibit 31: Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 32: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 33: Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
      • Exhibit 34: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
    • 6.4 Clinic - Market size and forecast 2023-2028
      • Exhibit 35: Chart on Clinic - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Data Table on Clinic - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 37: Chart on Clinic - Year-over-year growth 2023-2028 (%)
      • Exhibit 38: Data Table on Clinic - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Distribution Channel
      • Exhibit 39: Market opportunity by Distribution Channel ($ billion)
      • Exhibit 40: Data Table on Market opportunity by Distribution Channel ($ billion)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 41: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 42: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 43: Chart on Comparison by Type
      • Exhibit 44: Data Table on Comparison by Type
    • 7.3 Prescription - Market size and forecast 2023-2028
      • Exhibit 45: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 46: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 47: Chart on Prescription - Year-over-year growth 2023-2028 (%)
      • Exhibit 48: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
    • 7.4 Non-prescription - Market size and forecast 2023-2028
      • Exhibit 49: Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 51: Chart on Non-prescription - Year-over-year growth 2023-2028 (%)
      • Exhibit 52: Data Table on Non-prescription - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Type
      • Exhibit 53: Market opportunity by Type ($ billion)
      • Exhibit 54: Data Table on Market opportunity by Type ($ billion)

    8 Market Segmentation by Therapy Area

    • 8.1 Market segments
      • Exhibit 55: Chart on Therapy Area - Market share 2023-2028 (%)
      • Exhibit 56: Data Table on Therapy Area - Market share 2023-2028 (%)
    • 8.2 Comparison by Therapy Area
      • Exhibit 57: Chart on Comparison by Therapy Area
      • Exhibit 58: Data Table on Comparison by Therapy Area
    • 8.3 Musculoskeletal system - Market size and forecast 2023-2028
      • Exhibit 59: Chart on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 60: Data Table on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Chart on Musculoskeletal system - Year-over-year growth 2023-2028 (%)
      • Exhibit 62: Data Table on Musculoskeletal system - Year-over-year growth 2023-2028 (%)
    • 8.4 Nervous system - Market size and forecast 2023-2028
      • Exhibit 63: Chart on Nervous system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 64: Data Table on Nervous system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Chart on Nervous system - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on Nervous system - Year-over-year growth 2023-2028 (%)
    • 8.5 Respiratory system - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Respiratory system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on Respiratory system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on Respiratory system - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Respiratory system - Year-over-year growth 2023-2028 (%)
    • 8.6 Others - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 8.7 Market opportunity by Therapy Area
      • Exhibit 75: Market opportunity by Therapy Area ($ billion)
      • Exhibit 76: Data Table on Market opportunity by Therapy Area ($ billion)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 77: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 78: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 79: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 80: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 81: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 82: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 83: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 84: Abbott Laboratories - Overview
              • Exhibit 85: Abbott Laboratories - Business segments
              • Exhibit 86: Abbott Laboratories - Key offerings
              • Exhibit 87: Abbott Laboratories - Segment focus
            • 12.4 AbbVie Inc.
              • Exhibit 88: AbbVie Inc. - Overview
              • Exhibit 89: AbbVie Inc. - Product / Service
              • Exhibit 90: AbbVie Inc. - Key news
              • Exhibit 91: AbbVie Inc. - Key offerings
            • 12.5 AstraZeneca PLC
              • Exhibit 92: AstraZeneca PLC - Overview
              • Exhibit 93: AstraZeneca PLC - Product / Service
              • Exhibit 94: AstraZeneca PLC - Key news
              • Exhibit 95: AstraZeneca PLC - Key offerings
            • 12.6 Bayer AG
              • Exhibit 96: Bayer AG - Overview
              • Exhibit 97: Bayer AG - Business segments
              • Exhibit 98: Bayer AG - Key news
              • Exhibit 99: Bayer AG - Key offerings
              • Exhibit 100: Bayer AG - Segment focus
            • 12.7 Boehringer Ingelheim International GmbH
              • Exhibit 101: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 102: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 103: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 104: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 105: Boehringer Ingelheim International GmbH - Segment focus
            • 12.8 Bristol-Myers Squibb Company
              • Exhibit 106: Bristol-Myers Squibb Company - Overview
              • Exhibit 107: Bristol-Myers Squibb Company - Product / Service
              • Exhibit 108: Bristol-Myers Squibb Company - Key news
              • Exhibit 109: Bristol-Myers Squibb Company - Key offerings
            • 12.9 Eli Lilly and Co.
              • Exhibit 110: Eli Lilly and Co. - Overview
              • Exhibit 111: Eli Lilly and Co. - Product / Service
              • Exhibit 112: Eli Lilly and Co. - Key news
              • Exhibit 113: Eli Lilly and Co. - Key offerings
            • 12.10 F. Hoffmann La Roche Ltd.
              • Exhibit 114: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 116: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.11 GlaxoSmithKline Plc
              • Exhibit 119: GlaxoSmithKline Plc - Overview
              • Exhibit 120: GlaxoSmithKline Plc - Business segments
              • Exhibit 121: GlaxoSmithKline Plc - Key news
              • Exhibit 122: GlaxoSmithKline Plc - Key offerings
              • Exhibit 123: GlaxoSmithKline Plc - Segment focus
            • 12.12 Johnson and Johnson Services Inc.
              • Exhibit 124: Johnson and Johnson Services Inc. - Overview
              • Exhibit 125: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 126: Johnson and Johnson Services Inc. - Key news
              • Exhibit 127: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 128: Johnson and Johnson Services Inc. - Segment focus
            • 12.13 Merck and Co. Inc.
              • Exhibit 129: Merck and Co. Inc. - Overview
              • Exhibit 130: Merck and Co. Inc. - Business segments
              • Exhibit 131: Merck and Co. Inc. - Key news
              • Exhibit 132: Merck and Co. Inc. - Key offerings
              • Exhibit 133: Merck and Co. Inc. - Segment focus
            • 12.14 Novartis AG
              • Exhibit 134: Novartis AG - Overview
              • Exhibit 135: Novartis AG - Business segments
              • Exhibit 136: Novartis AG - Key news
              • Exhibit 137: Novartis AG - Key offerings
              • Exhibit 138: Novartis AG - Segment focus
            • 12.15 Pfizer Inc.
              • Exhibit 139: Pfizer Inc. - Overview
              • Exhibit 140: Pfizer Inc. - Product / Service
              • Exhibit 141: Pfizer Inc. - Key news
              • Exhibit 142: Pfizer Inc. - Key offerings
            • 12.16 Sanofi SA
              • Exhibit 143: Sanofi SA - Overview
              • Exhibit 144: Sanofi SA - Business segments
              • Exhibit 145: Sanofi SA - Key news
              • Exhibit 146: Sanofi SA - Key offerings
              • Exhibit 147: Sanofi SA - Segment focus
            • 12.17 Teva Pharmaceutical Industries Ltd.
              • Exhibit 148: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 149: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 150: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 151: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 152: Teva Pharmaceutical Industries Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 153: Inclusions checklist
                • Exhibit 154: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 155: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 156: Research methodology
                • Exhibit 157: Validation techniques employed for market sizing
                • Exhibit 158: Information sources
              • 13.5 List of abbreviations
                • Exhibit 159: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              pharmaceutical market in canada market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis